King of Prussia, PA, United States of America

Robert Glinecke

This inventor holds 2 USPTO granted patents. Top assignee: Other. Active years: 2002-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert Glinecke. Retrieved from https://idiyas.com/inventor/robert-glinecke-7apbfp0n

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.8

ph-index = 2

Forward Citations = 25(Granted Patents)


Location History:

  • Pottstown, PA (US) (2002)
  • King of Prussia, PA (US) (2010)

Company Filing History:

goldMedal2 out of 834,513 
Other
 patents

Years Active: 2002-2010

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Robert Glinecke

Introduction

Robert Glinecke is a notable inventor based in King of Prussia, PA (US). He has made significant contributions to the field of pharmaceuticals, holding 2 patents that showcase his innovative spirit and technical expertise. His work focuses on developing methods and apparatuses that enhance the assembly and delivery of pharmaceutical products.

Latest Patents

Glinecke's latest patents include a "Machine and method for pharmaceutical and pharmaceutical-like product assembly." This invention provides a method and apparatus for assembling a plurality of independently formed solid components, creating a single delivery vehicle for pharmaceutical or pharmaceutical-like products. The solid components can be held and fed to the apparatus via multiple magazines. Pusher rods are utilized for positioning each solid component, and a bonding liquid is applied to connect the components, which can also be secured using rivets or other connection structures.

Another significant patent is for a "Composition for treating dementia and Alzheimer's disease." This invention involves controlled release dosage forms that are useful in treating and preventing dementia, including Alzheimer's disease, in mammals. It aims to enhance amyloid precursor protein processing along a non-amyloidogenic pathway for patients at risk of developing Alzheimer's disease.

Career Highlights

Throughout his career, Robert Glinecke has demonstrated a commitment to advancing pharmaceutical technology. His innovative approaches have the potential to improve the efficacy and delivery of critical medications, particularly for conditions like Alzheimer's disease.

Collaborations

Glinecke has worked alongside talented individuals such as Laurence Rousseau and Ronnie Benditt, contributing to a collaborative environment that fosters innovation and creativity.

Conclusion

Robert Glinecke's contributions to the field of pharmaceuticals through his patents reflect his dedication to improving healthcare solutions. His inventions not only address pressing medical needs but also pave the way for future advancements in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…